7 Bright Spots in Aurora Cannabis' Otherwise Bleak Q2 Update
To no one's surprise, Aurora Cannabis (NYSE: ACB) reported dismal fiscal 2020 second-quarter results on Thursday. Aurora's revenue fell 26% from the prior quarter. The company posted another adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) loss that reflected a steep decline from Q1.
But while there was a lot to dislike about Aurora's Q2 results, the company's executives did discuss some good news in the quarterly conference call Thursday morning. Here are seven bright spots in Aurora's otherwise bleak Q2 update.
Image source: Getty Images.
Source Fool.com
